NasdaqGS - Nasdaq Real Time Price USD
Ultragenyx Pharmaceutical Inc. (RARE)
35.03
+0.68
+(1.98%)
At close: May 29 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
CROMBEZ ERIC M.D. Officer | Sale | May 5, 2025 | 71,530 |
DUNSIRE DEBORAH Director | Stock Award(Grant) | May 15, 2025 | 30,815 |
FUST MATTHEW K. Director | Stock Award(Grant) | May 15, 2025 | 25,945 |
HORN HOWARD Chief Financial Officer | Sale | Mar 6, 2025 | 106,169 |
KAKKIS EMIL D Chief Executive Officer | Sale | Mar 3, 2025 | -- |
NARACHI MICHAEL A Director | Stock Award(Grant) | May 15, 2025 | 32,690 |
RAY AMRIT Director | Stock Award(Grant) | May 15, 2025 | 23,365 |
SANDERS CORAZON CORSEE D Director | Stock Award(Grant) | May 15, 2025 | 17,749 |
SULIMAN SHEHNAAZ Director | Stock Award(Grant) | May 15, 2025 | 25,940 |
WELCH DANIEL G Director | Stock Award(Grant) | May 15, 2025 | 32,690 |
Related Tickers
MREO Mereo BioPharma Group plc
2.2100
+0.91%
AGIO Agios Pharmaceuticals, Inc.
31.84
+3.28%
PTCT PTC Therapeutics, Inc.
48.89
+3.41%
FOLD Amicus Therapeutics, Inc.
6.21
+1.80%
APLS Apellis Pharmaceuticals, Inc.
17.41
+3.63%
BPMC Blueprint Medicines Corporation
103.06
+8.14%
IONS Ionis Pharmaceuticals, Inc.
33.46
+3.18%
RGNX REGENXBIO Inc.
8.97
+5.04%
DNLI Denali Therapeutics Inc.
13.54
+3.83%
DAWN Day One Biopharmaceuticals, Inc.
6.48
+2.69%